In China, we transformed our manufacturing site in the city of Wuxi by implementing more than 30 digital tools and AI-powered solutions, and by developing a digital and agile workforce. This has helped maintain speed, efficiency and quality in an increasingly complex environment, boosting output by 55%, reducing lead time by 44%, decreasing non-perfect batches by 80%, and improving productivity by 54%. It is today independently ranked in the top 10% of more than 800 world class pharmaceutical sites in quality, speed and efficiency.
To-date, we have upskilled over 2,600 employees in the possibility of what Industry 4.0 technologies can enable, through internal exhibits, interactive training and hands on experience. We are tapping into external collaborations to train in data science, agile and change management, to drive our acceleration journey and to sustain a digital mindset. Importantly, our Operations and IT colleagues have established the first dedicated digital transformation office, bringing in digital networks within each value stream to drive scaling of solutions and generate new ideas.
Through the application of data visualisation and advanced analytics solutions, our Wuxi Site has built capabilities to optimise and synchronise production through real time, end-to-end visibility of demand, inventory, order status and process performance. As of 2022, the site now operates with even higher safety, quality and efficiency.
https://www.astrazeneca.com/what-science-can-do/topics/technologies/smart-factories-delivering-more-for-patients-worldwide.html#
http://www.wndonline.cn/2024-10/10/c_1030820.htm
https://investinchina.chinadaily.com.cn/s/202505/12/WS6821b0b3498eec7e1f736754/astrazeneca-breaks-ground-on-new-small-molecule-drug-factory-in-wuxi.html
No comments:
Post a Comment